HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoichi Hiasa Selected Research

DNA (Deoxyribonucleic Acid)

12/2021The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial.
1/2017Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
7/2007Characteristics of lamivudine-resistant hepatitis B virus (HBV) strains with and without breakthrough hepatitis in patients with chronic hepatitis B evaluated by serial HBV full-genome sequences.
1/2006Tracing the history of hepatitis B virus genotype D in western Japan.
2/2005In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoichi Hiasa Research Topics

Disease

139Hepatocellular Carcinoma (Hepatoma)
05/2024 - 11/2003
47Neoplasms (Cancer)
01/2024 - 11/2003
28Fibrosis (Cirrhosis)
04/2024 - 03/2007
25Non-alcoholic Fatty Liver Disease
04/2024 - 08/2010
24Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 06/2005
24Infections
09/2023 - 01/2006
21Chronic Hepatitis B
07/2023 - 02/2005
19Liver Neoplasms (Liver Cancer)
05/2024 - 03/2007
16Hypertension (High Blood Pressure)
04/2024 - 01/2016
16Chronic Hepatitis C
09/2023 - 01/2004
14Neoplasm Metastasis (Metastasis)
01/2024 - 01/2010
13Liver Diseases (Liver Disease)
01/2021 - 04/2002
12Inflammation (Inflammations)
04/2023 - 06/2011
12Type 2 Diabetes Mellitus (MODY)
05/2022 - 01/2016
11Ulcerative Colitis
12/2023 - 01/2021
10Alcoholic Fatty Liver
01/2023 - 08/2017
10Hepatitis B
04/2021 - 07/2007
9Ascites
05/2022 - 04/2007
9Insulin Resistance
07/2019 - 01/2007
8Hepatitis
07/2023 - 02/2005
8Fatty Liver
10/2021 - 01/2014
7Dyslipidemias (Dyslipidemia)
04/2024 - 01/2016
7Fatigue
01/2023 - 03/2011
7Diabetic Nephropathies (Diabetic Nephropathy)
03/2018 - 01/2014
6Thrombocytopenia (Thrombopenia)
02/2020 - 03/2007
6Chronic Hepatitis (Chronic Active Hepatitis)
07/2019 - 04/2002
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023 - 03/2012
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2013
5Diabetic Neuropathies (Diabetic Neuropathy)
03/2018 - 01/2016
5Diabetic Retinopathy (Retinopathy, Diabetic)
03/2018 - 01/2016
5Stroke (Strokes)
06/2017 - 01/2016
4Chemical and Drug Induced Liver Injury
12/2023 - 01/2015
4Autoimmune Hepatitis
12/2023 - 04/2002
4Portal Hypertension
12/2023 - 12/2011
4Hepatitis C
09/2023 - 04/2009
4Colitis
10/2022 - 03/2012
4Varicose Veins (Varicose Vein)
10/2022 - 12/2011
4Disease Progression
07/2021 - 06/2005
4Diabetes Mellitus
07/2019 - 05/2007
4Obesity
09/2018 - 03/2013
4Autoimmune Pancreatitis
02/2018 - 08/2011
4Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2011 - 04/2002
3Jaundice (Icterus)
02/2024 - 02/2007
3Rupture
01/2024 - 01/2015
3Hemorrhage
11/2023 - 01/2021
3Nocturia
11/2023 - 02/2018

Drug/Important Bio-Agent (IBA)

38Bevacizumab (Avastin)FDA Link
05/2024 - 01/2022
38atezolizumabIBA
05/2024 - 01/2022
38lenvatinibIBA
03/2024 - 01/2019
29AlbuminsIBA
05/2024 - 01/2009
23Antiviral Agents (Antivirals)IBA
12/2023 - 10/2007
21BilirubinIBA
05/2024 - 04/2009
16InterferonsIBA
05/2023 - 01/2004
15AntigensIBA
10/2022 - 04/2002
14VaccinesIBA
07/2023 - 07/2007
13alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2023 - 04/2006
13Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2023 - 01/2006
12CreatinineIBA
04/2024 - 01/2014
12Proteins (Proteins, Gene)FDA Link
01/2023 - 11/2003
11Alanine Transaminase (SGPT)IBA
04/2024 - 03/2007
11Ribavirin (Virazole)FDA LinkGeneric
02/2019 - 05/2007
10Glucose (Dextrose)FDA LinkGeneric
09/2023 - 09/2009
10Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2011
9Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
02/2024 - 01/2016
9Sorafenib (BAY 43-9006)FDA Link
01/2023 - 04/2013
8Hemoglobins (Hemoglobin)IBA
04/2024 - 09/2010
8Hepatitis B Core AntigensIBA
05/2023 - 08/2010
8B-Cell Activating FactorIBA
01/2023 - 08/2011
8C-Reactive ProteinIBA
01/2023 - 04/2013
7Messenger RNA (mRNA)IBA
01/2020 - 06/2005
6Fetal Proteins (Fetoprotein)IBA
05/2024 - 01/2017
6Serum AlbuminIBA
10/2023 - 03/2011
6Indicators and Reagents (Reagents)IBA
01/2023 - 01/2014
6Insulin (Novolin)FDA Link
07/2019 - 04/2011
6Amino AcidsFDA Link
01/2017 - 06/2007
5Triglycerides (Triacylglycerol)IBA
02/2024 - 01/2014
5Protein Kinases (Protein Kinase)IBA
01/2024 - 11/2003
5Palmitic Acid (Hexadecanoic Acid)IBA
10/2022 - 11/2012
5DNA (Deoxyribonucleic Acid)IBA
12/2021 - 02/2005
5CytokinesIBA
01/2021 - 08/2010
4nasIBA
04/2024 - 01/2020
4Tumor Biomarkers (Tumor Markers)IBA
08/2023 - 09/2008
4acarboxyprothrombin (PIVKA)IBA
08/2023 - 04/2013
4Carbon Tetrachloride (Tetrachloromethane)IBA
01/2023 - 01/2017
4Carbonic Anhydrase IIBA
10/2022 - 03/2012
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2022 - 02/2011
4Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 09/2008
4Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2017
4Branched-Chain Amino AcidsIBA
07/2019 - 04/2010
4Lamivudine (Epivir)FDA Link
10/2014 - 02/2005
4RNA (Ribonucleic Acid)IBA
01/2009 - 06/2005
3Uric Acid (Urate)IBA
02/2024 - 01/2014
3CholesterolIBA
02/2024 - 10/2022

Therapy/Procedure

77Therapeutics
05/2024 - 04/2002
27Radiofrequency Ablation
03/2024 - 12/2006
10Drug Therapy (Chemotherapy)
01/2022 - 01/2006
6Splenectomy
12/2020 - 03/2007
5Immunotherapy
05/2023 - 10/2005
5Liver Transplantation
04/2020 - 03/2007
3Stents
02/2024 - 04/2016